Shanghai Runda Medical Technology Co., Ltd. (603108.SS)
CNY 18.12
(3.13%)
CNY 18.12
(3.13%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 273.29 Million CNY | -58.28% |
| 2022 | 655.11 Million CNY | 9.51% |
| 2021 | 598.2 Million CNY | 18.73% |
| 2020 | 503.83 Million CNY | -1.42% |
| 2019 | 511.1 Million CNY | 95.11% |
| 2018 | 261.95 Million CNY | 19.51% |
| 2017 | 219.18 Million CNY | 88.26% |
| 2016 | 116.42 Million CNY | 26.88% |
| 2015 | 91.76 Million CNY | 22.08% |
| 2014 | 75.16 Million CNY | 10.63% |
| 2013 | 67.94 Million CNY | 15.55% |
| 2012 | 58.79 Million CNY | 7.89% |
| 2011 | 54.49 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 22.6 Million CNY | 322.55% |
| 2024 Q2 | 68.7 Million CNY | 203.94% |
| 2024 Q3 | -40.88 Million CNY | -159.5% |
| 2023 Q3 | 108.47 Million CNY | 15.47% |
| 2023 Q4 | -10.15 Million CNY | -109.36% |
| 2023 FY | 273.29 Million CNY | -58.28% |
| 2023 Q1 | 119.34 Million CNY | 6.84% |
| 2023 Q2 | 93.94 Million CNY | -21.29% |
| 2022 Q2 | 195.2 Million CNY | 144.37% |
| 2022 Q1 | 79.87 Million CNY | 45.98% |
| 2022 FY | 655.11 Million CNY | 9.51% |
| 2022 Q4 | 111.7 Million CNY | -51.92% |
| 2022 Q3 | 232.31 Million CNY | 19.01% |
| 2021 Q2 | 115.16 Million CNY | 28.31% |
| 2021 Q4 | 54.71 Million CNY | -53.83% |
| 2021 Q3 | 118.51 Million CNY | 2.91% |
| 2021 FY | 598.2 Million CNY | 18.73% |
| 2021 Q1 | 89.75 Million CNY | -4.71% |
| 2020 Q3 | 124.56 Million CNY | 56.62% |
| 2020 FY | 503.83 Million CNY | -1.42% |
| 2020 Q4 | 94.18 Million CNY | -24.39% |
| 2020 Q2 | 79.53 Million CNY | 150.97% |
| 2020 Q1 | 31.68 Million CNY | 80.82% |
| 2019 Q2 | 106.6 Million CNY | 56.91% |
| 2019 Q1 | 67.93 Million CNY | 262.51% |
| 2019 FY | 511.1 Million CNY | 95.11% |
| 2019 Q4 | 17.52 Million CNY | -85.08% |
| 2019 Q3 | 117.43 Million CNY | 10.16% |
| 2018 Q1 | 56.42 Million CNY | 9.37% |
| 2018 FY | 261.95 Million CNY | 19.51% |
| 2018 Q3 | 98.92 Million CNY | 12.6% |
| 2018 Q2 | 87.85 Million CNY | 55.69% |
| 2018 Q4 | 18.74 Million CNY | -81.06% |
| 2017 Q3 | 71.37 Million CNY | 13.27% |
| 2017 FY | 219.18 Million CNY | 88.26% |
| 2017 Q4 | 51.59 Million CNY | -27.71% |
| 2017 Q1 | 33.19 Million CNY | 4.89% |
| 2017 Q2 | 63.01 Million CNY | 89.83% |
| 2016 Q4 | 31.64 Million CNY | -12.56% |
| 2016 Q1 | 15.78 Million CNY | -47.87% |
| 2016 Q3 | 36.19 Million CNY | 10.34% |
| 2016 FY | 116.42 Million CNY | 26.88% |
| 2016 Q2 | 32.8 Million CNY | 107.75% |
| 2015 Q2 | 22.39 Million CNY | 72.49% |
| 2015 FY | 91.76 Million CNY | 22.08% |
| 2015 Q4 | 30.28 Million CNY | 16.08% |
| 2015 Q3 | 26.09 Million CNY | 16.51% |
| 2015 Q1 | 12.98 Million CNY | -57.69% |
| 2014 Q4 | 30.68 Million CNY | 73.34% |
| 2014 Q2 | 19.65 Million CNY | 175.91% |
| 2014 Q3 | 17.7 Million CNY | -9.94% |
| 2014 FY | 75.16 Million CNY | 10.63% |
| 2014 Q1 | 7.12 Million CNY | 0.0% |
| 2013 FY | 67.94 Million CNY | 15.55% |
| 2012 FY | 58.79 Million CNY | 7.89% |
| 2011 FY | 54.49 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Joinn Laboratories(China)Co.,Ltd. | 396.99 Million CNY | 31.158% |
| WuXi AppTec Co., Ltd. | 9.6 Billion CNY | 97.155% |
| Autobio Diagnostics Co., Ltd. | 1.21 Billion CNY | 77.552% |
| Thalys Medical Technology Group Inc. | -158.57 Million CNY | 272.349% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 643.38 Million CNY | 57.522% |
| Chemclin Diagnostics Co., Ltd. | 147.37 Million CNY | -85.445% |